CRISPR/Cas9-based targeting of fluorescent reporters to human iPSCs to isolate atrial and ventricular-specific cardiomyocytes
Abstract Generating cardiomyocytes (CMs) from human induced pluripotent stem cells (hiPSCs) has represented a significant advance in our ability to model cardiac disease. Current differentiation protocols, however, have limited use due to their production of heterogenous cell populations, primarily...
Guardado en:
Autores principales: | Orlando Chirikian, William R. Goodyer, Elda Dzilic, Vahid Serpooshan, Jan W. Buikema, Wesley McKeithan, HaoDi Wu, Guang Li, Soah Lee, Markus Merk, Francisco Galdos, Aimee Beck, Alexandre J. S. Ribeiro, Sharon Paige, Mark Mercola, Joseph C. Wu, Beth L. Pruitt, Sean M. Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d5033e1c1320405bbdfe19a5a5ff8a89 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Microhomology-assisted scarless genome editing in human iPSCs
por: Shin-Il Kim, et al.
Publicado: (2018) -
Dissecting transcriptomic signatures of neuronal differentiation and maturation using iPSCs
por: Emily E. Burke, et al.
Publicado: (2020) -
NaV1.5 knockout in iPSCs: a novel approach to study NaV1.5 variants in a human cardiomyocyte environment
por: Marion Pierre, et al.
Publicado: (2021) -
Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing
por: Erica McGrath, et al.
Publicado: (2019) -
Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases
por: Tao Ye, et al.
Publicado: (2021)